參考文獻(xiàn)/References:
[1] ZHAO X,XU D,LI Y,et al.MicroRNAs regulate bone metabolism[J].J Bone Miner Metab,2014,32(3):221-231.
[2] STEIN EM,KEPLEY A,WALKER M,et al.Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning[J].J Bone Miner Res,2014,29(5):1101-1109.
[3] WON Y,LIM JR,KIM YH,et al.Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate[J].J Bone Metab,2014,21(2):155-159.
[4] IGASE M,KOHARA K,TABARA Y,et al.Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis[J].Menopause,2014,21(9):962-966.
[5] LIANG W,LI X,LI Y,et al.Tongue coating microbiome regulates the changes in tongue texture and coating in patients with post-menopausal osteoporosis of Gan-shen deficiency syndrome type[J].Int J Mol Med,2013,32(5):1069-1076.
[6] LIANG W,LIM M,LI X,et al.Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line[J].Int J Mol Med,2012,30(4):889-895.
[7] CROSET M,SANTINI D,IULIANI M,et al.MicroRNAs and bone metastasis:a new challenge[J].Molecules,2014,19(7):10115-10128.
[8] CHOUDHURI S.Small noncoding RNAs:biogenesis,function,and emerging significance in toxicology[J].J Biochem Mol Toxicol,2010,24(3):195-216.
[9] SIOMI H,SIOMI MC.Posttranscriptional regulation of microRNA biogenesis in animals[J].Mol Cell,2010,38(3):323-332.
[10] LEE Y,KIM M,HAN J,et al.MicroRNA genes are transcribed by RNA polymerase II[J].EMBO J,2004,23(20):4051-4060.
[11] CARTHEW RW,SONTHEIMER EJ.Origins and Mechanisms of miRNAs and siRNAs[J].Cell,2009,136(4):642-655.
[12] DENLI AM,TOPS BB,PLASTERK RH,et al.Processing of primary microRNAs by the Microprocessor complex[J].Nature,2004,432(7014):231-235.
[13] KIM VN,HAN J,SIOMI MC.Biogenesis of small RNAs in animals[J].Nat Rev Mol Cell Biol,2009,10(2):126-139.
[14] YI R,QIN Y,MACARA IG,et al.Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs[J].Genes Dev,2003,17(24):3011-3016.
[15] BOHNSACK MT,CZAPLINSKI K,GORLICH D.Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs[J].RNA,2004,10(2):185-191.
[16] HAMMOND SM,BERNSTEIN E,BEACH D,et al.An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells[J].Nature,2000,404(6775):293-296.
[17] DJURANOVIC S,NAHVI A,GREEN R.A parsimonious model for gene regulation by miRNAs[J].Science,2011,331(6017):550-553.
[18] GUO H,INGOLIA NT,WEISSMAN JS,et al.Mammalian microRNAs predominantly act to decrease target mRNA levels[J].Nature,2010,466(7308):835-840.
[19] YANG JS,MAURIN T,ROBINE N,et al.Conserved vertebrate mir-451 provides a platform for Dicer-independent,Ago2-mediated microRNA biogenesis[J].Proc Natl Acad Sci USA,2010,107(34):15163-15168.
[20] GARNERO P.New developments in biological markers of bone metabolism in osteoporosis[J].Bone,2014,66:46-55.
[21] CAO Z,MOORE BT,WANG Y,et al.MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis[J].PLoS One,2014,9(5):e97098.
[22] WANG Y,LI L,MOORE BT,et al.MiR-133a in human circulating monocytes:a potential biomarker associated with postmenopausal osteoporosis[J].PLoS One,2012,7(4):e34641.
[23] LU Y,XIAO J,LIN H,et al.A single anti-microRNA antisense oligodeoxyribonucleotide(AMO)targeting multiple microRNAs offers an improved approach for microRNA interference[J].Nucleic Acids Res,2009,37(3):e24.
[24] EBERT MS,SHARP PA.MicroRNA sponges:progress and possibilities[J].RNA,2010,16(11):2043-2050.
[25] YOUNGER ST,COREY DR.Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters[J].Nucleic Acids Res,2011,39(13):5682-5691.
[26] SHI C,QI J,HUANG P,et al.MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells[J].Bone,2014,68:67-75.
[27] KATO RB,ROY B,DE OLIVEIRA FS,et al.Nanotopography directs mesenchymal stem cells to osteoblast lineage through regulation of microRNA-SMAD-BMP-2 circuit[J].J Cell Physiol,2014,229(11):1690-1696.
[28] CHEN L,HOLMSTRØM K,QIU W,et al.MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells[J].Stem Cells,2014,32(4):902-912.
[29] LUZI E,MARINI F,SALA SC,et al.Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor[J].J Bone Miner Res,2008,23(2):287-295.
[30] MIZUNO Y,YAGI K,TOKUZAWA Y,et al.miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation[J].Biochem Biophys Res Commun,2008,368(2):267-272.
[31] HUANG J,ZHAO L,XING L,et al.MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation[J].Stem Cells,2010,28(2):357-364.
[32] ITOH T,NOZAWA Y,AKAO Y.MicroRNA-141 and-200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5[J].J Biol Chem,2009,284(29):19272-19279.
[33] INOSE H,OCHI H,KIMURA A,et al.A microRNA regulatory mechanism of osteoblast differentiation[J].Proc Natl Acad Sci USA,2009,106(49):20794-20799.
[34] KAHAI S,LEE SC,LEE DY,et al.MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7[J].PLoS One,2009,4(10):e7535.
[35] KAPINAS K,KESSLER CB,DELANY AM.miR-29 suppression of osteonectin in osteoblasts:regulation during differentiation and by canonical Wnt signaling[J].J Cell Biochem,2009,108(1):216-224.
[36] WANG T,XU Z.miR-27 promotes osteoblast differentiation by modulating Wnt signaling[J].Biochem Biophys Res Commun,2010,402(2):186-189.
[37] LI H,XIE H,LIU W,et al.A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans[J].J Clin Invest,2009,119(12):3666-3677.
[38] MIZUNO Y,TOKUZAWA Y,NINOMIYA Y,et al.miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b[J].FEBS Lett,2009,583(13):2263-2268.
[39] 梁文娜,李西海,李燦東.絕經(jīng)后骨質(zhì)疏松的核心病機(jī)——骨痿[J].中國(guó)老年學(xué)雜志,2015,35(18):5333-5335.
[40] 梁文娜,李西海,李燦東,等.骨免疫與絕經(jīng)后骨質(zhì)疏松婦女骨重建失衡[J].國(guó)際骨科學(xué)雜志,2012,33(2):103-105.
[41] LI Y,LIANG W,LI X,et al.Effect of serum from postmenopausal women with osteoporosis exhibiting the Kidney-Yang deficiency pattern on bone formation in an hFOB 1.19 human osteoblastic cell line[J].Exp Ther Med,2015,10(3):1089-1095.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學(xué)朋,朱立國(guó).骨疏康膠囊對(duì)去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(10):12.
[3]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(10):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對(duì)絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(10):19.
[6]項(xiàng)旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(10):20.
[7]史曉林,李春雯,張志強(qiáng).弱陽(yáng)離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時(shí)間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(10):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(10):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(10):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(10):3.
[11]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對(duì)去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(10):7.
[12]歐國(guó)峰,劉鑫,董博,等.絕經(jīng)后骨質(zhì)疏松癥的免疫學(xué)研究進(jìn)展[J].中醫(yī)正骨,2016,28(08):70.
[13]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(10):1.
[14]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(10):1.
[15]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機(jī)制研究進(jìn)展[J].中醫(yī)正骨,2018,30(03):52.
[16]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動(dòng)物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過(guò)程中細(xì)胞自噬的機(jī)制[J].中醫(yī)正骨,2018,30(04):59.
[17]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽(yáng)虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(10):20.
[18]李中萬(wàn),徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽(yáng)虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(10):11.
[19]趙凡,劉全,吳連國(guó).口服強(qiáng)骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強(qiáng)骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(10):26.
[20]史曉林,楊依然,劉鐘,等.基于蛋白質(zhì)組學(xué)方法分析絕經(jīng)后骨質(zhì)疏松癥全血差異蛋白[J].中醫(yī)正骨,2019,31(06):7.
SHI Xiaolin,YANG Yiran,LIU Zhong,et al.Analysis of proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis using proteomics approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(10):7.